Virpax reports on progress of Envelta
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Government hospitals like AIIMS, KGMC & many more as per day OPD patients are 18-25 thousand
70+ CXOs from leading healthcare institutions across India attended the confluence at Mumbai
The facility is over 79,000 square feet and is equipped with packaging lines
The increase of stake in Aster DM Healthcare is a reiteration of the confidence in the business across geographies
The event witnessed a historic journey of Thalassemics India gracing the theme “LAKSH”
Women of all ages will get round-the-clock access to comprehensive treatment
Integration of modern and traditional medicine to facilitate the illness to wellness journey
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Subscribe To Our Newsletter & Stay Updated